Computational Bioactivity Fingerprint Similarities To Navigate the Discovery of Novel Scaffolds

Guo-Li Xiong,Yue Zhao,Lu Liu,Zhong-Ye Ma,Ai-Ping Lu,Yan Cheng,Ting-Jun Hou,Dong-Sheng Cao
DOI: https://doi.org/10.1021/acs.jmedchem.1c00234
IF: 8.039
2021-05-19
Journal of Medicinal Chemistry
Abstract:As one of the central tasks of modern medicinal chemistry, scaffold hopping is expected to lead to the discovery of structural novel biological active compounds and broaden the chemical space of known active compounds. Here, we report the computational bioactivity fingerprint (CBFP) for easier scaffold hopping, where the predicted activities in multiple quantitative structure–activity relationship models are integrated to characterize the biological space of a molecule. In retrospective benchmarks, the CBFP representation shows outstanding scaffold hopping potential relative to other chemical descriptors. In the prospective validation for the discovery of novel inhibitors of poly [ADP-ribose] polymerase 1, 35 predicted compounds with diverse structures are tested, 25 of which show detectable growth-inhibitory activity; beyond this, the most potent (compound 6) has an IC<sub>50</sub> of 0.263 nM. These results support the use of CBFP representation as the bioactivity proxy of molecules to explore uncharted chemical space and discover novel compounds.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.1c00234?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00234</a>.AMRR results for different screening datasets (Table S1 and Figure S1); PARP-1 inhibitors approved by FDA (Table S2); reverse target fishing of compound 6 and olaparib (Tables S3 and S4); information of the query data set (Table S5); the threshold of CBFP representation (Figure S2); workflow for CBFP construction (Figure S3) (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00234/suppl_file/jm1c00234_si_001.pdf">PDF</a>).Molecular formula strings of all the compounds tested and associated biochemical data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00234/suppl_file/jm1c00234_si_002.xlsx">XLSX</a>).Information on the QSAR models of CBFP representation (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00234/suppl_file/jm1c00234_si_003.csv">CSV</a>).This article has not yet been cited by other publications.
chemistry, medicinal
What problem does this paper attempt to address?